Skip to main content

Table 5 Shift from baseline to end-point (LOCF) in SDQ scale properties

From: Aripiprazole in the real-world treatment for irritability associated with autism spectrum disorder in children and adolescents in Japan: 52-week post-marketing surveillance

  SDQ scale properties at baseline (bandings of raw scores) SDQ scale properties at end-point (LOCF), n (%)
Low Need Some Need High Need Total
Conduct problems Low Need (0 to 3) 40 (76.9) 9 (17.3) 3 (5.8) 52 (100.0)
Some Need (4) 24 (51.1) 14 (29.8) 9 (19.1) 47 (100.0)
High Need (5 to 10) 44 (20.6) 39 (18.2) 131 (61.2) 214 (100.0)
Hyperactivity/inattention Low Need (0 to 5) 78 (87.6) 5 (5.6) 6 (6.7) 89 (100.0)
Some Need (6) 18 (46.2) 13 (33.3) 8 (20.5) 39 (100.0)
High Need (7 to 10) 56 (29.8) 27 (14.4) 105 (55.9) 188 (100.0)
Emotional symptoms Low Need (0 to 3) 99 (90.0) 4 (3.6) 7 (6.4) 110 (100.0)
Some Need (4) 20 (48.8) 9 (22.0) 12 (29.3) 41 (100.0)
High Need (5 to 10) 43 (25.7) 18 (10.8) 106 (63.5) 167 (100.0)
Peer problems Low Need (0 to 3) 26 (68.4) 5 (13.2) 7 (18.4) 38 (100.0)
Some Need (4) 9 (18.4) 25 (51.0) 15 (30.6) 49 (100.0)
High Need (5 to 10) 22 (9.7) 26 (11.5) 179 (78.9) 227 (100.0)
Total difficulties score Low Need (0 to 12) 20 (74.1) 3 (11.1) 4 (14.8) 27 (100.0)
Some Need (13 to 15) 14 (37.8) 16 (43.2) 7 (18.9) 37 (100.0)
High Need (16 to 40) 45 (18.4) 36 (14.7) 164 (66.9) 245 (100.0)
Prosocial behavior Low Need (6 to 10) 62 (81.6) 8 (10.5) 6 (7.9) 76 (100.0)
Some Need (5) 19 (41.3) 18 (39.1) 9 (19.6) 46 (100.0)
High Need (0 to 4) 29 (14.9) 24 (12.4) 141 (72.7) 194 (100.0)